Treatment of calvarial defects has remained a challenge in reconstruction surgery, especially because of infection at these sites. We produced a bactericidal biomaterial for treating infected bone defects by using calcium phosphate bone cement mixed with antibiotics. We evaluated the usefulness of this material mixed with the antibiotic vancomycin in a cranium-infected rat model. The concentration of vancomycin used was 5.0 wt%, as reported in our previous study. In order to establish the rat model, a cranium defect (diameter, 5 mm) was made that was infected with methicillin-resistant Staphylococcus aureus (MRSA). Thirty-six rats were divided into 6 groups depending on whether an autologous graft or bone cement with or without antibiotic was used for the defect. After 1 and 4 weeks, abscess formation was checked, tissue bacterial counts were determined, and pathological examination was performed. At both 1 and 4 weeks, no MRSA was detected on tissue bacterial culture or pathological examination in groups that received bone cement with antibiotics. In groups that received bone cement without antibiotic, MRSA was detected, and the bone cement had compromised and disintegrated into several slices. In conclusion, bone cement that contains antibiotics appears to be effective not only for reconstruction in cases of cranial defect, but also in terms of preventing infection.
Introduction
Treatment of calvarial defects remains a distinct challenge in reconstructive surgery. Clinical circumstances often require the reconstruction of an infected and chronically scarred wound. Standard treatment for these cases involves reconstruction using the autologous bone. However, standard, autogenous bone donor sites may yield small amounts of tissue and expose the patient to signifi cant donor-site morbidities such as infection, pain, hemorrhage, and nerve injury, which is the case in up to 10% patients with such defects. 1) Additionally, reconstruction using artifi cial bones, such as those constructed from titanium, hydroxyapatite, or other ceramics, is contraindicated because these constructs must be removed when infection spreads to the artifi cial bones. However, we hypothesized that if the infection were controlled, it might be possible to use artifi cial bones that would effectively eradicate infection.
The bactericidal or bacteriostatic effects of the antibiotic generally depend on the local concentration of the antibiotics. Therefore, a local delivery system enabling a sustained high concentration of antibiotics might be effective for controlling infections in calvarial defects.
In infected hip or knee replacements, treatment with calcium phosphate cement (CPC) beads with a high dose of antibiotics has proven useful. 2, 3) This method can probably be applied for cranial reconstruction. However, before clinical application of the procedure, an animal experiment is required to confi rm the effi cacy of this treatment. Therefore, in this study, we evaluated the effect of antibioticloaded CPC in the methicillin-resistant Staphylococcus aureus (MRSA)-infected experimental rat model.
Materials

I. Bone cement
In this study, we used Ceratouch bone cement (Ngk Spark Plug Co., Ltd, Aichi), which consists of powder [tetracalcium phosphate (TTCP) and anhydrous dibasic calcium phosphate] and a sclerosed solution (dextran sulfate sodium). Both the materials were mixed to produce hydroxyapatite (HA), according to the following reaction: 2Ca 4 (PO 4 ) 2 O + 2CaHPO 4 → Ca 10 (PO 4 ) 6 (OH) 2 . This reaction is slow, which allows us to mold the cement before it hardens after approximately 90 minutes at 25°C (i.e., room temperature, in vitro), and approximately 9 minutes at 37°C (i.e., in vivo). While hardening, the consistency of the cement remains at 50-200% for 17 minutes at 25°C. After 8 hours, the Ceratouch reaches its maximum compressive strength of approximately 50 Mpa.
The hardened Ceratouch has a porosity of 35%, and both open and closed pores have a ratio of 17.5%. Each pore is < 0.1 μm in diameter.
II. MRSA and Antibiotics
MRSA was clinically isolated from a surgical wound of a patient who had undergone neurosurgery, and the isolate was allowed to grow overnight on mannitol salt agar, after which individual colonies were incubated after 12 hours at 35°C. The cultured cells were then suspended in phosphate buffered saline (PBS) at a concentration of approximately 1.0 × 10 6 colony-forming units (CFU)/ml. Vancomycin (Shionogi Pharmaceutical, Osaka) was used as the antibiotic in our study; the optimal concentration to be mixed with CPC was 5.0 wt%, as obtained in our previous study.
4)
III. Sutures
Rats, mice, and other rodents are convenient models for handling; however, inducing infections in these animals is diffi cult as infections tend to heal in most cases, even after inoculation with bacteria. 5, 6) Therefore, it is necessary to prepare wounds surgically. For this, researchers have attempted to retain foreign bodies such as sutures, 7, 8) sand, 9) or dextran beads. 10, 11) Unlike sutures, sand and beads have not been used clinically. Therefore, in this study, we used sutures since their use has been reported in clinical medicine. We chose sutures from Surgion (Covidien, Mansfi eld, Massachusetts, USA), which are inert, non-absorbable sutures composed of the longchain, aliphatic polymers Nylon 6 and Nylon 6-6.
Methods
Male Slc:SD rats (weight, 200 g) were used in this study. Rats were anesthetized intraperitoneally using sodium thiopental (30 mg/kg). After this, the hair on their heads was removed with clippers; through a midline skin incision, the parietal skull was exposed, and a cranial bone defect of 5 mm in diameter was created bilaterally using a surgical tome (Fig. 1) . We then placed sutures at the defect sites. Either only PBS without MRSA (Groups 1, 3, 5) was injected or a 0.1 ml MRSA suspension (Groups 2, 4, 6) was injected into the bone defect. In each group, CPC with 5.0 wt% vancomycin (Groups 3 and 4) or CPC without vancomycin (Groups 5 and 6) was implanted into the defect. Finally, in Groups 1 and 2, the removed cranial bone was simply put back in place (Fig. 2) . Thus, in all there were 6 groups with 3 rats each ( Table 1 ). The procedure was performed on both sides of the rat cranium in each rat.
After surgery, all rats were housed in cages and provided food and water ad libitum. No dressing was applied. At the end of 1 and 4 weeks, the different groups of rats were sacrifi ced, and the calvarias were dissected to evaluate the degree of the defect repair. Six sides of three rats were assigned to each experimental group.
Of those, 2 × 2 mm of granulation tissues were taken from three sides of the rats in each group. These samples were transferred to a sterile bottle containing 10 ml of physiological saline and were homogenized for 2 minutes. A mannitol salt agar plate was inoculated with 10,000 times dilution of 
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0.1 ml of the solution and incubated for 24 hours at 37°C, after which time total viable counts were taken.
In the other three sides of the three rats from each group, the calvariae were harvested, fi xed in 10% neutral buffered formalin, and processed for paraffi n embedding. The specimens were sectioned in the coronal plane at a thickness of 5 μm and stained with hematoxylin-eosin for observation under a conventional qualitative, bright-fi eld light microscope.
Results
I. Macroscopic appearances
All groups that were not infected with MRSA and those that received the antibiotic had intact skin and no pyogenic mass in the subcutaneous layer at both 1 and 4 weeks.
Group 2 that received the autologous cranium and infection but no antibiotic had damaged skin and pyogenic masses in the subcutaneous layer after 1 week, but the wound was repaired and intact without pyogenic masses after 4 weeks. However, the grafted autologous cranium had changed in color and seemed to have undergone necrosis.
Similarly, Group 6 that received CPC and infection but no antibiotic, had damaged desiccated skin with pyogenic masses in the subcutaneous layer after 1 week. However, after 4 weeks, the CPC had disintegrated, and granulation was observed in the calvarial defect (Figs. 3, 4) .
II. Histology
The histologic analysis of Group 1 that received PBS and the autologous graft showed fi brous connective tissue around the grafted bone and neutrophils concentrated around the suture at 1 week. Similarly, both Groups 3 and 5 that did not receive infection but had undergone reconstruction with CPC with or without the antibiotics showed fi brous connective tissue and neutrophils around the artifi cial bone in their 1-week histologic analysis. The microscopic analysis at 1 week in Groups 2, 4, and 6 that had received infection indicated the presence of many neutrophils around the grafts and sutures. However, the number of neutrophils in Group 4 that received CPC with vancomycin was less than that in the two other groups (Fig. 5) .
In contrast, the microscopic analysis at 4 weeks, of Groups 1, 3, and 5 that were not infected, showed few neutrophils; however, that of Groups 2 and 6 has still showed neutrophil permeation, indicating the presence of MRSA infection. Additionally, the grafted autologous bone in Group 2 was thinner than that in Group 1. The artifi cial bone in Group 6 lost its original shape. However, in Group 4 that had received the antibiotic and CPC, the microscopic analysis indicated that the neutrophils had disappeared and the artifi cial bone had retained its shape. Fibrous connective tissue was observed between the conventional bone and the artifi cial bone, as observed in Groups 3 and 5 (Fig. 6) . 
III. Bacterial counts
The number of viable bacteria present in all biopsy specimens is shown in Fig. 7 . In Groups 1, 3, and 5, at both 1 and 4 weeks, no MRSA colony was observed. In Groups 2 and 4, the colony counts decreased observed at 4 weeks had reduced compared to that at 1 week, and the difference was signifi cant (p < 0.05). In contrast, there was no signifi cant difference in colony counts in Group 4 between 1 and 4 weeks (p = 0.28). The colony count in Group 4 was smaller than that in the other groups, and the difference was signifi cant (p < 0.05). 
Discussion
Currently, the commercially available antibiotics delivery system is antibiotics-loaded polymethyl methacrylate bone cement. 12, 13) The most frequently used treatment has been CPC, which consists of TTCP and educted HA by a hydration reaction. [14] [15] [16] According to previous in vitro study, the compressive strengths of CPC is lowered with antibiotics than without antibiotics and is < 40 Mpa. 4) This suggests that mixed cements would be diffi cult to use in joint arthroplasty, as vertebra spacers, for example, or for supplementation of femur defects. This is because these sites require compressive strengths of approximately 133 Mpa. 17) In contrast, the compressive strength of the skull is at least 31.1 Mpa.
18) Therefore, CPC with antibiotics might be useful in skull reconstruction.
Therefore, in the present study, infection sites were prepared at the cranium in the rat, and the effi ciency of antibiotic-loaded CPC was verifi ed. To our knowledge, this is the fi rst report to examine antibiotics-loaded CPC in vivo.
Our study showed that antibiotic-loaded CPC was useful for controlling infection. VCM activity is considered to be time-dependent; that is, antimicrobial activity depends on the duration that the serum drug concentration exceeds the minimum inhibitory concentration (MIC) of the target organism. The halflife of VCM was 4-5 hours, and VCM activity from single local administration with maximum dose was observed only for 12 hours. 19) Instead, our previous preliminary study noted that sustained release of VCM with exceeding the MIC from antibiotic-loaded CPC was observed for about 20 days. 4) It has been suggested that CPC has a microstructure and nanonetwork pass, which are useful for bone conduction, and would allow antibiotics diffusion. [2] [3] [4] From the same reason, the CPC might be useful for other time-dependent antibiotics such as cephembased and penicillin-based antibiotics might be useful as a drug carrier. However, our previous preliminary study noted that each antibiotic showed different infl uences on the characteristics of the bone cement. 4) We are going to study about the release rate of various antibiotics and mechanical properties of bone cements.
Considering clinical use, the most effective method is reconstruction for cranial defect after debridement; thus, in combination with antibiotics-loaded CPC and debridement, a high rate of effi ciency is expected. Furthermore, the other advantage is that simultaneous cranial reconstruction can be performed without donor site morbidity. In principle, the alloplastic have to be removed from the infection area, and cannot be used until controlling the infection. Otherwise, the use of the autologous graft tissue is recommended for simultaneous reconstruction. The use of antibiotics-loaded CPC can prevent the repeat operation and donor site morbidity.
Our study had certain limitations. This is an in vivo study using rats, and there are considerable biological differences between rats and humans. In particular, rats, mice, and other rodents mount strong immune defenses againt local infections, even after inoculation with bacteria. 5) In fact, our results also show that an autologous bone graft in Group 2 that received infection with MRSA alleviated the infection, although the thickness of bone grafts would be reduced by absorption. However, as all the specimens were prepared and tested in a uniform and reproducible manner and signifi cant differences were observed between autologous bone graft, bone cement with antibiotics, and bone cement without antibiotics, we believe that these results provide useful information.
Additionally, long-term examinations, particularly on the factors that limit antibiotic exposure to the infection site in bone conduction, will be necessary.
In summary, this in vivo study demonstrated theoretical advantages with bone cement mixed with antibiotics. Unlike other cements that have been studied, bone cement with a microstructure and nano-network may be useful not only as a fi ller for cranial reconstruction, but also as a drug carrier. Future studies should examine longer release times of the antibiotics or the use of other drugs, such as bone morphogenetic protein. 
